Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04096170 · ClinicalTrials.gov registry record · Phase 4
Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo
A Phase 4 study of Hernia, Paraesophageal, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT04096170: Recruiting Phase 4 study of Hernia, Paraesophageal, sponsored by Wake Forest University Health Sciences.
NCT04096170 is a Phase 4 study of Hernia, Paraesophageal that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 50 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04096170, a Phase 4 study of Hernia, Paraesophageal, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
We aim to study the impact of perioperative IV lidocaine on postoperative pain control in patients undergoing paraesophageal hernia repair. This is in the context of an established ERAS protocol. We wish to study the effect of IV Lidocaine on postoperative short and long-term outcomes, including patients' length of stay postoperative mortality, morbidity, and quality of life. We will compare this to our standard pain management.
Primary Outcome
Postoperative consumption of morphine equivalents
Conditions Studied
Interventions
- DRUG Placebo
- DRUG IV lidocaine
Study Locations (1)
North Carolina
- Atrium Health - Carolinas Medical Center - Charlotte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2018-06-21 |
| Est. Completion | 2026-05 |
| Phase | Phase 4 |
What NCT04096170 shows while recruiting
NCT04096170 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (90% lower).
The record links to 1 condition, with Hernia, Paraesophageal appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04096170 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04096170 about?
NCT04096170 is a clinical study titled "Improving Pain Control in Paraesophageal Hernia Repair: Intravenous Lidocaine Versus Placebo". We aim to study the impact of perioperative IV lidocaine on postoperative pain control in patients undergoing paraesophageal hernia repair. This is in the context of an established ERAS protocol. We wish to study the effect of IV Lidocaine on postoperative short and long-term outcomes, including pat...
What is the current status of trial NCT04096170?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2018-06-21. Estimated completion is 2026-05.
What conditions does trial NCT04096170 study?
This clinical trial studies the following conditions: Hernia, Paraesophageal.
What interventions are being tested in trial NCT04096170?
The interventions under investigation include: Placebo (DRUG), IV lidocaine (DRUG).
Who is sponsoring clinical trial NCT04096170?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04096170 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04096170's enrollment target sits among peer trials
50 1255th of 2000 higher than 679 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI